• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白-蛋白相互作用促进 E4orf6 依赖性调节 HAdV-C5 感染中的 E1B-55K SUMOylation。

Protein-Protein Interactions Facilitate E4orf6-Dependent Regulation of E1B-55K SUMOylation in HAdV-C5 Infection.

机构信息

Department of Viral Transformation, Leibniz Institute for Experimental Virology (HPI), 20251 Hamburg, Germany.

Center for Biomedical Education and Research (ZBAF), Department of Human Medicine, Faculty of Health, Institute of Virology and Microbiology, Witten/Herdecke University, 58453 Witten, Germany.

出版信息

Viruses. 2022 Feb 24;14(3):463. doi: 10.3390/v14030463.

DOI:10.3390/v14030463
PMID:35336871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8953357/
Abstract

The human adenovirus type C5 (HAdV-C5) E1B-55K protein is a multifunctional regulator of HAdV-C5 replication, participating in many processes required for maximal virus production. Its multifunctional properties are primarily regulated by post-translational modifications (PTMs). The most influential E1B-55K PTMs are phosphorylation at highly conserved serine and threonine residues at the C-terminus, and SUMO conjugation to lysines 104 (K104) and 101 (K101) situated in the N-terminal region of the protein, which have been shown to regulate each other. Reversible SUMO conjugation provides a molecular switch that controls key functions of the viral protein, including intracellular trafficking and viral immune evasion. Interestingly, SUMOylation at SUMO conjugation site (SCS) K104 is negatively regulated by another multifunctional HAdV-C5 protein, E4orf6, which is known to form a complex with E1B-55K. To further evaluate the role of E4orf6 in the regulation of SUMO conjugation to E1B-55K, we analyzed different virus mutants expressing E1B-55K proteins with amino acid exchanges in both SCS (K101 and K104) in the presence or absence of E4orf6. We could exclude phosphorylation as factor for E4orf6-mediated reduction of E1B-55K SUMOylation. In fact, we demonstrate that a direct interaction between E1B-55K and E4orf6 is required to reduce E1B-55K SUMOylation. Additionally, we show that an E4orf6-mediated decrease of SUMO conjugation to K101 and K104 result in impaired co-localization of E1B-55K and SUMO in viral replication compartments. These findings indicate that E4orf6 inhibits E1B-55K SUMOylation, which could favor assembly of E4orf6-dependent E3 ubiquitin ligase complexes that are known to degrade a variety of host restriction factors by proteasomal degradation and, thereby, promote viral replication.

摘要

人腺病毒 C 型 5(HAdV-C5)E1B-55K 蛋白是 HAdV-C5 复制的多功能调节剂,参与病毒产生所需的许多过程。其多功能特性主要受翻译后修饰(PTMs)调控。E1B-55K 最具影响力的 PTM 是 C 末端高度保守丝氨酸和苏氨酸残基的磷酸化,以及 SUMO 与蛋白 N 端区域赖氨酸 104(K104)和 101(K101)的缀合,这两者已被证明可以相互调节。可逆的 SUMO 缀合提供了一个分子开关,控制病毒蛋白的关键功能,包括细胞内运输和病毒免疫逃逸。有趣的是,SUMO 缀合位点(SCS)K104 的 SUMOylation 受到另一种多功能 HAdV-C5 蛋白 E4orf6 的负调控,E4orf6 已知与 E1B-55K 形成复合物。为了进一步评估 E4orf6 在调节 E1B-55K 的 SUMO 缀合中的作用,我们分析了在存在或不存在 E4orf6 的情况下,表达 E1B-55K 蛋白的不同病毒突变体中,SCS(K101 和 K104)处的氨基酸交换。我们可以排除磷酸化是 E4orf6 介导的 E1B-55K SUMOylation 减少的因素。事实上,我们证明 E1B-55K 和 E4orf6 之间的直接相互作用是减少 E1B-55K SUMOylation 的必要条件。此外,我们还表明,E4orf6 介导的 K101 和 K104 的 SUMO 缀合减少导致 E1B-55K 和 SUMO 在病毒复制隔间中的共定位受损。这些发现表明,E4orf6 抑制 E1B-55K SUMOylation,这可能有利于 E4orf6 依赖性 E3 泛素连接酶复合物的组装,这些复合物已知通过蛋白酶体降解来降解多种宿主限制因子,从而促进病毒复制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/fc53982fcc99/viruses-14-00463-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/9c6b91d566c2/viruses-14-00463-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/1a3f8d768989/viruses-14-00463-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/b48cca9e9657/viruses-14-00463-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/c31dbe7b7c99/viruses-14-00463-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/fc53982fcc99/viruses-14-00463-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/9c6b91d566c2/viruses-14-00463-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/1a3f8d768989/viruses-14-00463-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/b48cca9e9657/viruses-14-00463-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/c31dbe7b7c99/viruses-14-00463-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6817/8953357/fc53982fcc99/viruses-14-00463-g005.jpg

相似文献

1
Protein-Protein Interactions Facilitate E4orf6-Dependent Regulation of E1B-55K SUMOylation in HAdV-C5 Infection.蛋白-蛋白相互作用促进 E4orf6 依赖性调节 HAdV-C5 感染中的 E1B-55K SUMOylation。
Viruses. 2022 Feb 24;14(3):463. doi: 10.3390/v14030463.
2
E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.E1B-55K 介导的 RNF4 SUMO 靶向泛素连接酶的调节促进人腺病毒基因表达。
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.00164-18. Print 2018 Jul 1.
3
Conserved E1B-55K SUMOylation in Different Human Adenovirus Species Is a Potent Regulator of Intracellular Localization.不同型人腺病毒中保守的 E1B-55K SUMOylation 是一种有效的细胞内定位调节剂。
J Virol. 2022 Feb 9;96(3):e0083821. doi: 10.1128/JVI.00838-21. Epub 2021 Nov 17.
4
Cellular SUMO-specific proteases regulate HAdV-C5 E1B-55K SUMOylation and virus-induced cell transformation.细胞 SUMO 特异性蛋白酶调节 HAdV-C5 E1B-55K SUMO 化和病毒诱导的细胞转化。
Front Cell Infect Microbiol. 2024 Sep 27;14:1484241. doi: 10.3389/fcimb.2024.1484241. eCollection 2024.
5
Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.腺病毒E4-ORF3靶向PIAS3,并与E1B-55K共同重塑细胞核和病毒基因组复制区域中的小泛素样修饰蛋白(SUMO)相互作用。
J Virol. 2015 Oct;89(20):10260-72. doi: 10.1128/JVI.01091-15. Epub 2015 Jul 29.
6
The E3 ubiquitin ligase activity associated with the adenoviral E1B-55K-E4orf6 complex does not require CRM1-dependent export.腺病毒 E1B-55K-E4orf6 复合物相关的 E3 泛素连接酶活性不需要 CRM1 依赖性输出。
J Virol. 2011 Jul;85(14):7081-94. doi: 10.1128/JVI.02368-10. Epub 2011 May 11.
7
Adenovirus E1B-55K controls SUMO-dependent degradation of antiviral cellular restriction factors.腺病毒 E1B-55K 控制 SUMO 依赖性降解抗病毒细胞限制因子。
J Virol. 2023 Nov 30;97(11):e0079123. doi: 10.1128/jvi.00791-23. Epub 2023 Nov 2.
8
The adenovirus E1B-55K oncoprotein induces SUMO modification of p53.腺病毒E1B - 55K癌蛋白诱导p53的SUMO修饰。
Cell Cycle. 2008 Mar 15;7(6):754-8. doi: 10.4161/cc.7.6.5495.
9
Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies.腺病毒 E1B 55 千道尔顿蛋白是一种 p53-SUMO1 E3 连接酶,通过与早幼粒细胞白血病核体的相互作用,抑制 p53 并刺激其核输出。
J Virol. 2010 Dec;84(23):12210-25. doi: 10.1128/JVI.01442-10. Epub 2010 Sep 22.
10
Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes.人类腺病毒 C 型 5 E1 癌基因对细胞 FAM111B 的差异调控。
Viruses. 2021 May 28;13(6):1015. doi: 10.3390/v13061015.

引用本文的文献

1
Adenovirus E1B-55K interferes with cellular IκB kinase complex subunit proteins.腺病毒E1B - 55K干扰细胞IκB激酶复合体亚基蛋白。
Front Immunol. 2025 Mar 4;16:1532742. doi: 10.3389/fimmu.2025.1532742. eCollection 2025.
2
Cellular SUMO-specific proteases regulate HAdV-C5 E1B-55K SUMOylation and virus-induced cell transformation.细胞 SUMO 特异性蛋白酶调节 HAdV-C5 E1B-55K SUMO 化和病毒诱导的细胞转化。
Front Cell Infect Microbiol. 2024 Sep 27;14:1484241. doi: 10.3389/fcimb.2024.1484241. eCollection 2024.
3
Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif.

本文引用的文献

1
E1B-55K Is a Phosphorylation-Dependent Transcriptional and Posttranscriptional Regulator of Viral Gene Expression in Human Adenovirus C5 Infection.E1B-55K 是人类腺病毒 C5 感染中病毒基因表达的依赖于磷酸化的转录和转录后调节因子。
J Virol. 2022 Mar 9;96(5):e0206221. doi: 10.1128/jvi.02062-21. Epub 2022 Jan 12.
2
Conserved E1B-55K SUMOylation in Different Human Adenovirus Species Is a Potent Regulator of Intracellular Localization.不同型人腺病毒中保守的 E1B-55K SUMOylation 是一种有效的细胞内定位调节剂。
J Virol. 2022 Feb 9;96(3):e0083821. doi: 10.1128/JVI.00838-21. Epub 2021 Nov 17.
3
CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells.
通过共同结合基序鉴定腺病毒 E1B-55K 相互作用伙伴。
Viruses. 2023 Nov 30;15(12):2356. doi: 10.3390/v15122356.
4
Adenovirus E1B-55K controls SUMO-dependent degradation of antiviral cellular restriction factors.腺病毒 E1B-55K 控制 SUMO 依赖性降解抗病毒细胞限制因子。
J Virol. 2023 Nov 30;97(11):e0079123. doi: 10.1128/jvi.00791-23. Epub 2023 Nov 2.
5
The human adenovirus E1B-55K oncoprotein coordinates cell transformation through regulation of DNA-bound host transcription factors.人腺病毒 E1B-55K 癌蛋白通过调节与 DNA 结合的宿主转录因子来协调细胞转化。
Proc Natl Acad Sci U S A. 2023 Oct 31;120(44):e2310770120. doi: 10.1073/pnas.2310770120. Epub 2023 Oct 26.
6
The emerging roles of SUMOylation in pulmonary diseases.SUMOylation 在肺部疾病中的新兴作用。
Mol Med. 2023 Sep 5;29(1):119. doi: 10.1186/s10020-023-00719-1.
7
Functions and mechanisms of protein lysine butyrylation (Kbu): Therapeutic implications in human diseases.蛋白质赖氨酸丁酰化(Kbu)的功能与机制:对人类疾病的治疗意义
Genes Dis. 2022 Nov 29;10(6):2479-2490. doi: 10.1016/j.gendis.2022.10.025. eCollection 2023 Nov.
8
Apobec3A Deamination Functions Are Involved in Antagonizing Efficient Human Adenovirus Replication and Gene Expression.Apobec3A 脱氨酶功能参与拮抗有效的人腺病毒复制和基因表达。
mBio. 2023 Jun 27;14(3):e0347822. doi: 10.1128/mbio.03478-22. Epub 2023 May 8.
基于 CRISPR/Cas9 的人乳头瘤病毒致癌基因 E6 或 E7 的失活诱导宫颈癌细胞衰老。
Virology. 2021 Oct;562:92-102. doi: 10.1016/j.virol.2021.07.005. Epub 2021 Jul 14.
4
Fluorescent protein tagging of adenoviral proteins pV and pIX reveals 'late virion accumulation compartment'.荧光蛋白标记腺病毒蛋白 pV 和 pIX 揭示“晚期病毒粒子积累隔室”。
PLoS Pathog. 2020 Jun 25;16(6):e1008588. doi: 10.1371/journal.ppat.1008588. eCollection 2020 Jun.
5
Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.病毒 DNA 结合蛋白 SUMOylation 促进 PML 核体定位于病毒复制中心附近。
mBio. 2020 Mar 17;11(2):e00049-20. doi: 10.1128/mBio.00049-20.
6
The biology of the adenovirus E1B 55K protein.腺病毒 E1B 55K 蛋白的生物学特性。
FEBS Lett. 2019 Dec;593(24):3504-3517. doi: 10.1002/1873-3468.13694. Epub 2019 Dec 8.
7
Formation of adenovirus DNA replication compartments.腺病毒 DNA 复制隔室的形成。
FEBS Lett. 2019 Dec;593(24):3518-3530. doi: 10.1002/1873-3468.13672. Epub 2019 Nov 26.
8
Adenovirus persistence, reactivation, and clinical management.腺病毒持续性感染、再激活与临床管理。
FEBS Lett. 2019 Dec;593(24):3571-3582. doi: 10.1002/1873-3468.13576. Epub 2019 Sep 8.
9
A review of 65 years of human adenovirus seroprevalence.对人类腺病毒血清流行率 65 年的回顾。
Expert Rev Vaccines. 2019 Jun;18(6):597-613. doi: 10.1080/14760584.2019.1588113. Epub 2019 May 27.
10
Human Adenovirus Core Protein V Is Targeted by the Host SUMOylation Machinery To Limit Essential Viral Functions.人类腺病毒核心蛋白V被宿主SUMO化机制靶向,以限制病毒的基本功能。
J Virol. 2018 Jan 30;92(4). doi: 10.1128/JVI.01451-17. Print 2018 Feb 15.